Weak demand across its customer base weighed on sales volumes and competition from Asian rivals forced it to lower some ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Lanxess AG (ETR:LXS) on Thursday reported fourth quarter adjusted EBITDA of €102 million, beating analyst consensus of €100 million by 2%, though full-year 202 ...
LANXESS Aktiengesellschaft (ETR:LXS) executives used the company’s 2025 financial statement press conference to describe what ...
Speciality chemicals maker Lanxess on Thursday reported weaker-than-expected annual sales and said it did not expect ...
By Ozan Ergenay March 19 (Reuters) - Speciality chemicals maker Lanxess on Thursday reported annual sales below market ...
Lanxess posted 2025 annual sales of €5.67B, missing market estimates in a weak environment. Revenue fell from €6.36B in 2024, ...
Lanxess said it was raising chemical prices to counter the effects of the Middle East conflict, after the speciality ...
Lanxess shares hit a 17-year low after Advent cancels its purchase of the remaining Envalior stake, impacting the German chemical sector.
Lanxess AG shares fell to their lowest since 2009 after the German chemicals company failed to complete an asset sale, raising concerns it could lose its investment-grade credit rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results